$GNBT Recent Headlines Wednesday’s biggest gaining

New Post Public Reply Private Reply Replies (0) Message Board

Oct 13, 2014 at 1:39 PM

$GNBT Recent Headlines

Wednesday’s biggest gaining and declining stocks 6:20 p.m. Oct. 20, 2010 - Kate Gibson
Progress on Diabetes, Cancer Treatments 7:04 p.m. Jan. 14, 2010 - Alexander Davis
Sunesis, Generex, Cubist lead drug stocks higher 2:29 p.m. Dec. 14, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:25 p.m. Dec. 9, 2009 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 3:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 5:33 p.m. Dec. 3, 2009 - MarketWatch
Endo falls on FDA move; Generex rallies 1:25 p.m. Dec. 3, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 6:00 p.m. Sept. 11, 2009 - MarketWatch
Thursday's biggest gaining and declining stocks 5:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 2:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy
Drug stocks inch lower while broader market gains 3:27 p.m. June 4, 2009 - Val Brickates Kennedy
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
As diabetes surges, the search for better treatments intensifies 5:33 p.m. Nov. 25, 2008 - Sara Sargent
Generex Bio says share decline linked to Eli Lilly, Novo Nordisk moves 8:20 a.m. March 11, 2008 - Dow Jones
Drug stocks slide; Mannkind, Alkermes fall for second day 4:48 p.m. March 10, 2008 - Val Brickates Kennedy
CORRECTS: Some small-cap stocks may get hit in '08, but not all 7:18 p.m. Jan. 16, 2008 - MarketWatch
The big picture is often misleading on stocks 9:05 a.m. Jan. 16, 2008 - Chuck Jaffe

10-K: GENEREX BIOTECHNOLOGY CORP 4:05 p.m. Oct. 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
With Ebola Looming, When Will The Defense Department Get Around To Generex? 3:22 a.m. Oct. 1, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 4:14 p.m. June 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Provectus: Strong Sell, Ties To Paid Stock Promoters, SEC Halt Risk, Price Target $0 10:40 a.m. May 21, 2014 - Seeking Alpha
Provectus: Ties To Paid Stock Promoters, SEC Halt Risk, History Of Shareholder Wipeouts 10:40 a.m. May 21, 2014 - Seeking Alpha
Generex registers convertible shares 4:21 p.m. April 4, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 5:03 p.m. March 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Emerging Biotech Takes Aim At Preventing Recurrent Breast Cancer 11:12 a.m. Jan. 21, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 5:40 p.m. Dec. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Generex: A Stock Suitable Only For Its Officers And Directors Or Carl Icahn 11:08 a.m. Dec. 2, 2013 - Seeking Alpha
10-K: GENEREX BIOTECHNOLOGY CORP 4:39 p.m. Oct. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: GENEREX BIOTECHNOLOGY CORP 5:05 p.m. June 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
Stocks at New Highs, News Lows for 12/3 5:33 a.m. Dec. 3, 2012 - InvestorPlace.com
Weekly CFO Sells Highlight: TDG, GNBT, ADGE, HFC, AMSWA 4:20 p.m. July 2, 2012 - GuruFocus.com
An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA) 7:14 a.m. May 18, 2012 - 247WallSt.com
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN) 12:00 p.m. May 10, 2012 - 247WallSt.com
Generex Biotechnology Corp. Reports Operating Results (10-Q) 5:47 p.m. Dec. 12, 2011 - GuruFocus.com
Weekly Healthcare Stock Watch 11:01 a.m. Oct. 5, 2011 - Seeking Alpha
Generex Corporate Update: The potential Is there 10:11 a.m. Aug. 4, 2011 - Seeking Alpha
Stocks To Watch This Week: DNDN, MNKD, CLDX 4:35 a.m. June 27, 2011 - Seeking Alpha

Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine 9:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project 9:30 a.m. Sept. 30, 2014 - PR Newswire - PRF
Generex Collaborates with University Health Network for Buccal Insulin Project 9:30 a.m. Sept. 22, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in BioPharm America™ 2014 9:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Generex Announces Publication of AE37 Prostate Cancer Vaccine Study 9:30 a.m. Aug. 6, 2014 - PR Newswire - PRF
Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation 9:30 a.m. June 17, 2014 - PR Newswire - PRF
Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial 9:30 a.m. June 12, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in 2014 BIO International Convention 9:30 a.m. June 10, 2014 - PR Newswire - PRF
Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO 9:30 a.m. May 20, 2014 - PR Newswire - PRF
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting 9:30 a.m. April 23, 2014 - PR Newswire - PRF
Generex Announces $2,075,000 Capital Investment 9:30 a.m. March 27, 2014 - PR Newswire - PRF
Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium 9:30 a.m. March 26, 2014 - PR Newswire - PRF
Generex Biotechnology Corp. Granted Patents on New HPV and Influenza Vaccines 12:01 p.m. March 12, 2014 - ACCESSWIRE
Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza 10:30 a.m. March 5, 2014 - PR Newswire - PRF
Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients 10:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Generex/Antigen Express Interview on Clear Channel Business Talk Radio DFW 1190AM by Host Michael Yorba 11:27 a.m. Feb. 12, 2014 - Marketwire
Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial 10:30 a.m. Feb. 12, 2014 - PR Newswire - PRF
Generex/Antigen Express "Stock News Now" Interview Available Online 12:32 p.m. Feb. 4, 2014 - PR Newswire - PRF
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial 10:30 a.m. Jan. 13, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VISTAR Oakland Workers Join Teamsters for Unity

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Nomada Fund Launches: A Game-Changer in New Media

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

D2L Ventures into Vietnam with Van Lang Alliance

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Community Heritage Financial Declares Q3 2026 Dividend

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Kenneth Smith Takes Helm for Trends Int’l Expansion

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Standex's New Financial Lead: Stoddard Takes Helm

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...